What is Core Technology Solutions?
Core Technology Solutions, Inc. operates as an integrated entity focused on the research, development, and manufacturing of transdermal patch products. The company specializes in both proprietary and generic controlled-release formulations, positioning itself as a key innovator in transdermal drug delivery systems. Its expertise spans membrane-controlled and matrix-controlled patch designs, offering comprehensive services from initial development through to scale-up and commercial manufacturing. This integrated approach allows Core Technology Solutions to manage the entire product lifecycle, ensuring quality and efficiency in bringing advanced drug delivery solutions to market.
How much funding has Core Technology Solutions raised?
Core Technology Solutions has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Core Technology Solutions
PPP
Public-Private Partnership
What's next for Core Technology Solutions?
With the recent influx of capital, Core Technology Solutions is poised for accelerated growth and further development of its transdermal technologies. The large-scale, late-stage funding suggests a strategic focus on scaling operations, expanding market reach, and potentially advancing its pipeline of controlled-release patch products. This investment will likely fuel further research into novel delivery mechanisms and enhance manufacturing capabilities to meet growing market demand. The company's trajectory points towards solidifying its leadership in the specialized field of transdermal medicine, with potential for strategic partnerships and broader commercialization efforts.
See full Core Technology Solutions company page
